Olema Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $48.3M | $139.5M | $68.5M | $23.7M | $13.8M | $338.5M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $515.5M | $438.5M | $266.5M | $208.9M | $290.7M | $342.1M |
| Property, Plant & Equipment | $274.0K | $746.0K | $968.0K | $1.5M | $1.5M | $75.0K |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $533.4M | $451.0M | $276.9M | $215.6M | $295.9M | $342.7M |
| Liabilities | ||||||
| Accounts Payable | $9.3M | $4.5M | $2.7M | $374.0K | $23.0K | $719.0K |
| Total Current Liabilities | $51.8M | $41.8M | $21.6M | $16.5M | $9.0M | $4.6M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $54.9M | $42.0M | $23.1M | $18.1M | $11.4M | $4.6M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-597.6M | $-435.1M | $-305.6M | $-209.0M | $-104.2M | $-33.1M |
| Total Stockholders' Equity | $478.6M | $409.0M | $253.9M | $197.5M | $284.6M | $338.1M |